Geode Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.52 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
48Shares Held
12.1MCall Options Held
620KPut Options Held
31.4K-
Diadema Partners LP Morristown, NJ2.51MShares$1.25 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$961,6140.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.71MShares$855,6100.0% of portfolio
-
Persistent Asset Partners LTD Hong Kong, K3594KShares$296,9510.15% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA524KShares$262,0250.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $10.2M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...